Alert detail
LCD L39646: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — Palmetto GBA
What changed
Palmetto GBA finalizes molecular thyroid nodule risk testing coverage rules.
Who’s affected: Endocrinology billing teams · Effective: March 13, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.